Molecular evaluation of ablative therapy of Barrett's oesophagus.
about
Treatment for Barrett's oesophagusProtoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.Biomarkers in Barrett's Esophagus.Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagusBritish Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.Correlation of the presence and extent of loss of heterozygosity mutations with histological classifications of Barrett's esophagus.Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers.Prostate PDT dosimetry.Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience.Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus.Barrett's esophagus: where do we stand?Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma.Molecular biomarkers and ablative therapies for Barrett's esophagus.Endoscopic resection (endoscopic submucosal dissection/endoscopic mucosal resection) for superficial Barrett's esophageal cancer.Endoscopic resection techniques and ablative therapies for Barrett's neoplasia.MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control studyBarrett's esophagus: endoscopic treatments I
P2860
Q24240701-7B63192A-5AB8-41CC-AFCE-3C1578858C53Q33252347-7B0DE801-67A2-46DB-BF74-503EA22EE392Q34011000-4DBDB4D8-578A-4099-B6B7-74ACABC1B7BEQ34309843-66CE11C3-5A4B-4FD9-A12B-DECC079FD8A1Q34380645-FF5C2B0D-F171-48F0-AB9A-9BC237BC4CADQ34523644-F14B58C3-37C1-4B3B-8318-4ACB563CB605Q35031044-059B7712-B5A9-46C6-9185-0ABE1D1D5A0BQ35748396-AE943BAA-4568-4D92-B83C-A0E15DF087F2Q36475728-C71AE637-F93E-499A-888A-CF86C3C11C2DQ37085332-76A3D220-FCFF-4FE3-A1D9-721A4D9CA44AQ37243629-AC7603AB-08BC-490A-988A-11ABDE33E053Q37741832-C0BA6A23-7758-4D99-A91C-A6ABEA5977DAQ38051702-33106B28-3865-419B-B6CD-008172F3AE74Q38088328-D610379F-4005-4A0D-AAF3-F93E6C205610Q38567106-97BFE22F-D1E6-4C95-A7AD-0EBAA36E9FBCQ41426289-CE74710D-5CB8-4CA9-B3DE-5F741B43409EQ57259815-AA1E6FC5-5F2F-4166-A54E-8DE8D3CB3ED1Q57546190-2615FA6D-0F00-4533-B0B7-9BA8FC73B785
P2860
Molecular evaluation of ablative therapy of Barrett's oesophagus.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Molecular evaluation of ablative therapy of Barrett's oesophagus.
@ast
Molecular evaluation of ablative therapy of Barrett's oesophagus.
@en
type
label
Molecular evaluation of ablative therapy of Barrett's oesophagus.
@ast
Molecular evaluation of ablative therapy of Barrett's oesophagus.
@en
prefLabel
Molecular evaluation of ablative therapy of Barrett's oesophagus.
@ast
Molecular evaluation of ablative therapy of Barrett's oesophagus.
@en
P2093
P356
P1476
Molecular evaluation of ablative therapy of Barrett's oesophagus.
@en
P2093
Herman van Dekken
Jelle Haringsma
Kees J Vissers
Mariska Hage
Peter D Siersema
P356
10.1002/PATH.1685
P577
2005-01-01T00:00:00Z